The unfinished analysis “certainly raised some red flags,” Florida’s former insurance commissioner told lawmakers.

Yaworsky said it could have been dropped because regulators were understaffed and dealing with the height of the insurance ...

Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...